HINNAO NAD+

Why choose HINNAO NAD+(Nicotinamide Adenine Dinucleotide)

Until Now NAD+ has only been available in IV drip therapy clinics, due to the molecule not being stable. Using clinically proven high-stability liposomes, as a delivery mechanism HINNAO NAD+ absorbs instantly via the mucous membrane crossing the blood brain barrier.

NAD+ levels will typically half by the time we hit our 50’s compared to what they were in their 20’s.

Absorption in Seconds

HINNAO® Technology uses a high shear process subjecting the particles to 40,000 psi encapsulating the particles uniformly, the phospholipid MCT base, ensures the product cannot fall out, creating high stability liposomes for increased bioavailability.

NAD+ levels will typically half by the time we hit our 50’s compared to what they were in their 20’s. Low NAD+ levels are associated with ageing and being more prone to chronic diseases such as  diabetes, heart disease, Alzheimer’s disease and vision loss.